Rogue Scientist Who Gene-Hacked Human Babies Gear Up for More Human Experiments
5 Articles
5 Articles
Rogue Scientist Who Gene-Hacked Human Babies Gear Up for More Human Experiments
That rogue scientist who created HIV-resistant designer babies is apparently gearing up for more human gene-editing research. In an interview with the Wall Street Journal, He Jiankui said he wants to conduct human trials on his next big project: encoding genetics to prevent Alzheimer's disease, a heritable illness, in future generations. He identified South Africa, where the government declared in 2024 that it's open to the "significant potentia…
Chinese scientist responsible for "Gene-Edited Babies" seeks to make comeback
Jiankui, the Chinese scientist infamous for creating the world’s first gene-edited babies, is attempting a controversial comeback. After serving a three-year prison sentence for his unauthorized experiments, He is now focusing on a new project aimed at preventing Alzheimer’s disease through gene editing. He Jiankui shocked the world in 2018 when he announced the birth […]
How biotech reinvented itself, hid the dangers and pretended safety - Daily Telegraph NZ
‘Sir’ Ashley Bloomfield, formerly Director General of Health and the public face of Covid in NZ, has taken to the media to warn us that another pandemic will be flying our way courtesy of Bird Flu. An article in Stuff newspaper reports that Bloomfield wants us to ‘prepare for the worst in the not too distant future’. Apparently, Bloomfield thinks that the main lesson of the Covid pandemic five years on amounts to being ready for the next virus t…
Chinese Scientist Ostracized Over Gene-Edited Babies Seeks Comeback
(Wall Street Journal) – He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection. Now, the self-styled gene editing pioneer is trying to stage a comeback with another controversial proj…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage